XT
HUMA icon

XTX Topco’s Humacyte HUMA Stock Holding History

XTX Topco’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-412,090
Closed -$250K – 4383
2026
Q1 		$250K Sell
412,090
-238,768
-37% -$248K ﹤0.01% 2649
2025
Q4 		$625K Buy
650,858
+457,236
+236% +$647K 0.02% 1404
2025
Q3 		$337K Sell
193,622
-97,266
-33% -$191K 0.02% 1417
2025
Q2 		$608K Buy
290,888
+237,091
+441% +$455K 0.03% 964
2025
Q1 		$91.7K Buy
53,797
+9,868
+22% +$37K ﹤0.01% 1887
2024
Q4 		$222K Buy
43,929
+9,880
+29% +$48.9K 0.02% 1474
2024
Q3 		$185K Buy
34,049
+11,172
+49% +$73.7K 0.01% 1467
2024
Q2 		$110K Buy
+22,877
New +$119K 0.01% 1399
2023
Q1 		– Sell
-10,088
Closed -$21.3K – 1452
2022
Q4 		$21.3K Buy
+10,088
New +$30.6K ﹤0.01% 1069

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

XTX Topco's HUMA Position: Q2 2026 in Review

XTX Topco sold out of Humacyte (HUMA) in Q2 2026, closing a stake of 412,090 shares — an estimated $250K sold.

XTX Topco first reported a position in HUMA in Q4 2022 and held it in 9 quarters. The position peaked at $625K in Q4 2025. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • XTX Topco reported no remaining Humacyte position as of Q2 2026 after selling out during the quarter.
  • XTX Topco sold 412,090 Humacyte shares in Q2 2026, an estimated $250K.
  • XTX Topco first reported a position in Humacyte in Q4 2022 and held it in 9 quarters.
  • XTX Topco's Humacyte position peaked at $625K in Q4 2025.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.